SARS-CoV-2 and Acute Cerebrovascular Events: An Overview
Open Access
- 29 July 2021
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (15), 3349
- https://doi.org/10.3390/jcm10153349
Abstract
Since the coronavirus disease 2019 (COVID-19) pandemic, due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, accumulating evidence indicates that SARS-CoV-2 infection may be associated with various neurological manifestations, including acute cerebrovascular events (i.e., stroke and cerebral venous thrombosis). These events can occur prior to, during and even after the onset of COVID-19’s general symptoms. Although the mechanisms underlying the cerebrovascular complications in patients with COVID-19 are yet to be fully elucidated, the hypercoagulability state, inflammation and altered angiotensin-converting enzyme 2 (ACE-2) signaling in association with SARS-CoV-2 may play key roles. ACE-2 plays a critical role in preserving heart and brain homeostasis. In this review, we discuss the current state of knowledge of the possible mechanisms underlying the acute cerebrovascular events in patients with COVID-19, and we review the current epidemiological studies and case reports of neurovascular complications in association with SARS-CoV-2, as well as the relevant therapeutic approaches that have been considered worldwide. As the number of published COVID-19 cases with cerebrovascular events is growing, prospective studies would help gather more valuable insights into the pathophysiology of cerebrovascular events, effective therapies, and the factors predicting poor functional outcomes related to such events in COVID-19 patients.This publication has 100 references indexed in Scilit:
- Therapeutic potential of the renin angiotensin system in ischaemic strokeExperimental & Translational Stroke Medicine, 2016
- Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumoniaCellular & Molecular Immunology, 2016
- Mechanical Thrombectomy in Cerebral Venous ThrombosisStroke, 2015
- Overview of the coagulation systemIndian Journal of Anaesthesia, 2014
- Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivoThe Journal of Experimental Medicine, 2012
- Acute Lung Injury Is an Independent Risk Factor for Brain Hypoxia After Severe Traumatic Brain InjuryNeurosurgery, 2010
- ACE2 Activation Promotes Antithrombotic ActivityMolecular Medicine, 2010
- Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung InjuryCell, 2008
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Antithrombotic Effect of Captopril and Losartan Is Mediated by Angiotensin-(1-7)Hypertension, 2002